← Back to Search

Aerobic Exercise for Fallopian Tube Adenocarcinoma

N/A
Waitlist Available
Led By Kathryn Pennington
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 weeks
Awards & highlights

Study Summary

This trial will study whether moderate exercise can improve quality of life for people with ovarian cancer.

Eligible Conditions
  • Fallopian Tube Adenocarcinoma
  • Fallopian Tube Cancer
  • Peritoneal Carcinosarcoma
  • Ovarian Cancer
  • Ovarian Carcinoma
  • Peritoneal Carcinoma
  • Fallopian Tube Carcinoma
  • Ovarian Carcinosarcoma
  • Ovarian Adenocarcinoma
  • Ovarian Brenner Tumor
  • Endometrioid Adenocarcinoma
  • Fallopian Tube Carcinosarcoma
  • Peritoneal Serous Adenocarcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Distress, Measured Using the Hospital Anxiety and Depression Scale - Anxiety Subscale
Change in Distress, Measured Using the Hospital Anxiety and Depression Scale - Depression Subscale
Change in Distress, Measured Using the Perceived Stress Scale
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (aerobic exercise)Experimental Treatment5 Interventions
Participants meet with exercise physiologist for 1, 60 minute session. Participants then receive individualized exercise prescription with goal of moderate aerobic exercise over 150 minutes per week at home for up to 24 weeks. Participants also receive telephone-based motivational support by exercise physiologist weekly for 24 weeks.
Group II: Arm II (habitual level of physical activity)Active Control3 Interventions
Participants maintain habitual levels of physical activity and receive general education material about ovarian cancer and survivorship for 24 weeks. After 24 weeks, participants are offered exercise intervention.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,702 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,790 Total Patients Enrolled
6 Trials studying Fallopian Tube Adenocarcinoma
3,443 Patients Enrolled for Fallopian Tube Adenocarcinoma
Kathryn PenningtonPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
Kathryn Pennington 2018. "The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03641287.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top